Sojitz Corporation Introduces ‘N-NOSE’ for Early Detection of Cancer in Employees and Their Families

2022.11.11

We are pleased to announce that our N-NOSE has been introduced as part of Sojitz Corporation’s efforts to maintain and promote health for its employees.
A location for the submission of N-NOSE specimens has been established at the Sojitz Corporation’s Tokyo Head Office/Kansai Branch Clinic.

We will continue to provide the N-NOSE for early detection of cancer and to support corporate health management as well as to contribute to raising health awareness throughout society.